Abstract
In this paper, the authors review the history of the pharmacological treatment of bipolar disorder, from the first nonspecific sedative agents introduced in the 19th and early 20th century, such as solanaceae alkaloids, bromides and barbiturates, to John Cade’s experiments with lithium and the beginning of the so-called “Psychopharmacological Revolution” in the 1950s. We also describe the clinical studies and development processes, enabling the therapeutic introduction of pharmacological agents currently available for the treatment of bipolar disorder in its different phases and manifestations. Those drugs include lithium salts, valproic acid, carbamazepine, new antiepileptic drugs, basically lamotrigine and atypical antipsychotic agents (olanzapine, risperidone, quetiapine, ziprasidone, aripiprazole, asenapine, cariprazine and lurasidone). Finally, the socio-sanitary implications derived from the clinical introduction of these drugs are also discussed.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference223 articles.
1. A Greek-English Lexicon;Liddell,1940
2. Predictive animal models of mania: hits, misses and future directions
3. Nosographie Philosphique ou La Methode De L’analyse Appliquee a La Medecine;Pinel,1818
4. El saber psiquiátrico en la segunda mitad del siglo XIX: La somatización de la enfermedad mental;Huertas;Historia 16,1993
5. Psychiatrie. Ein Lehrbuch Für Studirende Und Aerzte. Sechste, Vollständig Umgearbeitete Auflage;Kraepelin,1899
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献